Literature DB >> 439319

Heparin-induced spinal fractures.

J W Squires, L W Pinch.   

Abstract

A 27-year-old woman received heparin sodium for 152 days because of antepartum iliofemoral thrombophlebitis. At the end of this time, spinal osteoporosis and multiple vertebral fractures became clinically evident and were attributed to the prolonged administration of heparin. Previously reported cases of "heparin osteoporosis" were reviewed. The significance of the daily dose of heparin and the duration of therapy are reemphasized. This therapeutic complication and the management of antepartum iliofemoral thrombophlebitis are discussed. Prolonged administration of heparin in daily doses exceeding 10,000 units is potentially hazardous.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 439319

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

1.  Effect of medication on biomechanical properties of rabbit bones: heparin induced osteoporosis.

Authors:  N Akkas; Y N Yeni; B Turan; E Delilbasi; U Gunel
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 2.  The osteoporosis of heparinotherapy and systemic mastocytosis.

Authors:  T Bardin; M Lequesne
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

3.  Verapamil induces increased bone volume and osteopenia in female rats but has the opposite effect in male rats.

Authors:  E Samnegård; G Sjödén
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

Review 4.  Heparin therapy. Regimens and treatment considerations.

Authors:  T M Hyers
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

5.  Effects of short-term, high dose, heparin therapy on biochemical markers of bone metabolism.

Authors:  F Cantini; L Niccoli; F Bellandi; O Di Munno
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

6.  Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption.

Authors:  A J Crisp; J K Wright; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

Review 7.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

8.  Effect of a direct thrombin inhibitor compared with dalteparin and unfractionated heparin on human osteoblasts.

Authors:  Tobias Winkler; Carsten Perka; Dörte Matziolis; Georg Matziolis
Journal:  Open Orthop J       Date:  2011-03-16

9.  The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin.

Authors:  Gandhi N Solayar; Pauline M Walsh; Kevin J Mulhall
Journal:  BMC Musculoskelet Disord       Date:  2011-10-28       Impact factor: 2.362

Review 10.  The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.

Authors:  Andrew D Blann; Chee W Khoo
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.